1,948 followers
RT @ERheumat: 🔥🆕JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis ♦️Skin fibrosis and digital u…
RT @ERheumat: 🔥🆕JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis ♦️Skin fibrosis and digital u…
JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis. https://t.co/d23yZAO1on
RT @ERheumat: 🔥🆕JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis ♦️Skin fibrosis and digital u…
RT @ERheumat: 🔥🆕JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis ♦️Skin fibrosis and digital u…